Cystic fibrosis: new insights from infection to inflammation
DAY 3
Chaired by: Professor Robert Gray (Glasgow) and Dr Dawn Lau (Cardiff)
9:00am - Covering changing microbial ecology and potential new approaches such as phage therapy
Professor Jo Fothergil (Liverpool)
9:30am - What can we learn from large animal models of CF and non-CF Bronchiectasis?
Professor David Stoltz (USA)
10:00am - Exploring how understanding non-pathogen driven autoinflammation may be the key to treating residual inflammation in the CF lung following CFTR modulator therapy
Professor Daniel Peckham (Leeds)
9:00 AM
90 MINUTE SESSION
Learning objectives
- To understand how lung microbiology has changed in CF and how new approaches are needed in anti-microbial therapy.
- To learn how pre-clinical models in CF and non-CF muco-obstructive diseases can lead to the development of new treatments.
- To determine the role of autoinflammatory pathways in CF and how they might be modulated.